[go: up one dir, main page]

MX2009011641A - Agentes de liberacion para dispositivo de implante y metodos para utilizar los mismos. - Google Patents

Agentes de liberacion para dispositivo de implante y metodos para utilizar los mismos.

Info

Publication number
MX2009011641A
MX2009011641A MX2009011641A MX2009011641A MX2009011641A MX 2009011641 A MX2009011641 A MX 2009011641A MX 2009011641 A MX2009011641 A MX 2009011641A MX 2009011641 A MX2009011641 A MX 2009011641A MX 2009011641 A MX2009011641 A MX 2009011641A
Authority
MX
Mexico
Prior art keywords
methods
same
release agents
implant device
release agent
Prior art date
Application number
MX2009011641A
Other languages
English (en)
Inventor
Harry Quandt
Stefanie Decker
Petr Kuzma
Original Assignee
Endo Pharmaceuticals Solutions
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endo Pharmaceuticals Solutions filed Critical Endo Pharmaceuticals Solutions
Publication of MX2009011641A publication Critical patent/MX2009011641A/es

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C33/00—Moulds or cores; Details thereof or accessories therefor
    • B29C33/56—Coatings, e.g. enameled or galvanised; Releasing, lubricating or separating agents
    • B29C33/60—Releasing, lubricating or separating agents
    • B29C33/62—Releasing, lubricating or separating agents based on polymers or oligomers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C41/00—Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped article; Apparatus therefor
    • B29C41/02—Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped article; Apparatus therefor for making articles of definite length, i.e. discrete articles
    • B29C41/08—Coating a former, core or other substrate by spraying or fluidisation, e.g. spraying powder
    • B29C41/085—Coating a former, core or other substrate by spraying or fluidisation, e.g. spraying powder by rotating the former around its axis of symmetry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mechanical Engineering (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Se preparan dispositivos de implante médico a partir de un material polimérico y un agente de liberación, en donde el dispositivo es un implante de depósito, moldeado, y el agente de liberación tiene un peso molecular (PM) de al menos 1000; el agente de liberación puede ser un agente tensoactivo no iónico tal como Brij 35, trioleato de polioxietilen(20) sorbitán, Tween 20, Tween 80 vitamina E TPGS, y una mezcla de cualquiera de dos o más de los mismos; los implantes hidratados pueden tener un área superficial de alrededor de 500 mm o mayor.
MX2009011641A 2007-04-27 2008-04-25 Agentes de liberacion para dispositivo de implante y metodos para utilizar los mismos. MX2009011641A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91451107P 2007-04-27 2007-04-27
PCT/US2008/061511 WO2008134475A2 (en) 2007-04-27 2008-04-25 Implant device release agents and methods of using same

Publications (1)

Publication Number Publication Date
MX2009011641A true MX2009011641A (es) 2010-03-04

Family

ID=39539634

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009011641A MX2009011641A (es) 2007-04-27 2008-04-25 Agentes de liberacion para dispositivo de implante y metodos para utilizar los mismos.

Country Status (15)

Country Link
US (1) US9120249B2 (es)
EP (1) EP2139533A2 (es)
JP (3) JP5855826B2 (es)
KR (1) KR101574354B1 (es)
CN (1) CN101720239B (es)
AU (1) AU2008245710B2 (es)
BR (1) BRPI0810606B1 (es)
CA (1) CA2685397C (es)
IL (1) IL201734A (es)
MX (1) MX2009011641A (es)
NZ (1) NZ580803A (es)
RU (1) RU2463079C2 (es)
TW (1) TWI450734B (es)
WO (1) WO2008134475A2 (es)
ZA (1) ZA200907516B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7759312B2 (en) * 2005-03-11 2010-07-20 Endo Pharmaceuticals Solutions Inc. Delivery of dry formulations of octreotide
KR101399911B1 (ko) 2005-03-11 2014-06-19 엔도 파마슈티컬즈, 솔루션스 아이엔씨. 옥트레오타이드의 방출 조절형 제형
JP5855826B2 (ja) 2007-04-27 2016-02-09 エンド ファーマスーティカルズ ソリューションズ インコーポレイテッド．Ｅｎｄｏ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｓｏｌｕｔｉｏｎｓ Ｉｎｃ． デバイス、及びレザバーインプラントデバイスの製造方法
US7960335B2 (en) * 2008-06-25 2011-06-14 Endo Pharmaceuticals Solutions Inc. Octreotide implant having a release agent and uses thereof
WO2009158412A2 (en) 2008-06-25 2009-12-30 Endo Pharmaceuticals Solutions Inc. Sustained delivery of exenatide and other polypeptides
CN101973094B (zh) * 2010-11-08 2013-07-03 大连三达奥克化学股份有限公司 气雾罐型塑料模具脱模剂及制造方法
CN106310394B (zh) * 2015-07-01 2020-03-06 先健科技(深圳)有限公司 铁基可吸收植入医疗器械及其制备方法
GB201523102D0 (en) * 2015-12-30 2016-02-10 Augmented Optics Ltd Electrically active hydrophilic bio-polymers
CN110142901B (zh) * 2019-06-17 2021-05-18 江苏力凡胶囊有限公司 一种用于空心胶囊的脱模剂及其制备方法
WO2025107053A1 (pt) * 2023-11-23 2025-05-30 Meira Salomao Ambrizzi Gabriela Barreira protetora de feridas cirúrgicas e não cirúrgicas e isoladora de tecidos

Family Cites Families (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2168331A (en) 1936-10-17 1939-08-08 Du Pont Cast resin with integral sheen
US2513014A (en) 1946-11-18 1950-06-27 Abbott Lab Apparatus for implanting medicinal pellets subcutaneously
GB1306541A (en) 1969-01-20 1973-02-14 Ceskoslovenska Akademie Ved Method of manufacturing tubes by centrifugal casting
US3876581A (en) * 1972-10-10 1975-04-08 Erickson Polymer Corp Hydrophilic polymer composition for prosthetic devices
US3921632A (en) 1974-08-16 1975-11-25 Frank M Bardani Implant device
US4131604A (en) 1977-11-23 1978-12-26 Thermo Electron Corporation Polyurethane elastomer for heart assist devices
US4285987A (en) 1978-10-23 1981-08-25 Alza Corporation Process for manufacturing device with dispersion zone
US4298002A (en) 1979-09-10 1981-11-03 National Patent Development Corporation Porous hydrophilic materials, chambers therefrom, and devices comprising such chambers and biologically active tissue and methods of preparation
US4386039A (en) 1980-02-11 1983-05-31 Thermo Electron Corporation Process for forming an optically clear polyurethane lens or cornea
US4523005A (en) 1981-10-30 1985-06-11 Thermedics, Inc. Extrudable polyurethane for prosthetic devices prepared from a diisocyanate, a polytetramethylene ether polyol, and 1,4-butane diol
US4751133A (en) 1984-11-13 1988-06-14 Thermedics, Inc. Medical patches and processes for producing same
US5342622A (en) 1986-05-16 1994-08-30 The State Of Victoria Subdermal biocompatible implants
US4959217A (en) 1986-05-22 1990-09-25 Syntex (U.S.A.) Inc. Delayed/sustained release of macromolecules
US4743673A (en) 1986-12-19 1988-05-10 Tyndale Plains-Hunter, Ltd. Hydrophilic carboxy polyurethanes
US4871094A (en) 1986-12-31 1989-10-03 Alcon Laboratories, Inc. Means and method for dispensing substances
US4994028A (en) 1987-03-18 1991-02-19 Endocon, Inc. Injector for inplanting multiple pellet medicaments
US4846793A (en) 1987-03-18 1989-07-11 Endocon, Inc. Injector for implanting multiple pellet medicaments
AU608891B2 (en) 1987-09-24 1991-04-18 Merck & Co., Inc. Solubility modulated drug delivery device
US5035891A (en) 1987-10-05 1991-07-30 Syntex (U.S.A.) Inc. Controlled release subcutaneous implant
US4954587A (en) 1988-07-05 1990-09-04 Ciba-Geigy Corporation Dimethylacrylamide-copolymer hydrogels with high oxygen permeability
GB8820353D0 (en) 1988-08-26 1988-09-28 Staniforth J N Controlled release tablet
RU2104084C1 (ru) 1989-02-16 1998-02-10 Бритиш Технолоджи Груп Лимитед Капсула дозируемого выброса
PH30995A (en) 1989-07-07 1997-12-23 Novartis Inc Sustained release formulations of water soluble peptides.
US5273752A (en) 1989-07-18 1993-12-28 Alza Corporation Controlled release dispenser comprising beneficial agent
US5023313A (en) * 1989-07-27 1991-06-11 Edwards Bill R Acrylic resin composition
US5468811A (en) 1989-11-02 1995-11-21 National Patent Development Corporation Hydrophilic composite polymer articles formed from a settable paste comprising a mixture of hydrophilic polymer and unsaturated monomer
US5254662A (en) 1990-09-12 1993-10-19 Polymedia Industries, Inc. Biostable polyurethane products
US5266325A (en) 1990-09-28 1993-11-30 Hydro Med Science Division Of National Patent Development Corp. Preparation of homogeneous hydrogel copolymers
AU651654B2 (en) 1992-01-14 1994-07-28 Endo Pharmaceuticals Solutions Inc. Manufacture of water-swellable hydrophilic articles and drug delivery devices
DK0550641T3 (da) 1990-09-28 1994-08-22 Pfizer Dispenseringsanordning indeholdende et hydrofobt medium
AU652984B2 (en) 1992-01-14 1994-09-15 Endo Pharmaceuticals Solutions Inc. Preparation of homogeneous hydrogel copolymers
JP2530079B2 (ja) 1992-02-05 1996-09-04 ナショナル・パテント・ディベロプメント・コーポレーション 水分膨潤性親水性製品及び薬物放出装置の製造
US5614223A (en) 1992-05-04 1997-03-25 Digestive Care Inc. Intraoral medicament-releasing device
US5354835A (en) 1993-07-23 1994-10-11 Saudi Basic Industries Corporation Desalination process
KR950007873A (ko) 1993-09-20 1995-04-15 후꾸하라 요시하루 생리 활성 물질 지속 방출형의 의약 제제
JPH07252166A (ja) 1993-09-20 1995-10-03 Shiseido Co Ltd 徐放性製剤
JPH0797338A (ja) 1993-09-20 1995-04-11 Shiseido Co Ltd 徐放性製剤
US5904935A (en) 1995-06-07 1999-05-18 Alza Corporation Peptide/protein suspending formulations
US5817343A (en) 1996-05-14 1998-10-06 Alkermes, Inc. Method for fabricating polymer-based controlled-release devices
US5945128A (en) 1996-09-04 1999-08-31 Romano Deghenghi Process to manufacture implants containing bioactive peptides
AUPO251096A0 (en) 1996-09-23 1996-10-17 Cardiac Crc Nominees Pty Limited Polysiloxane-containing polyurethane elastomeric compositions
US6093559A (en) 1996-10-24 2000-07-25 Corning Incorporated Producing low binding hydrophobic surfaces by treating with a low HLB number non-ionic surfactant
US5756127A (en) 1996-10-29 1998-05-26 Wright Medical Technology, Inc. Implantable bioresorbable string of calcium sulfate beads
US5854127A (en) 1997-03-13 1998-12-29 Micron Technology, Inc. Method of forming a contact landing pad
FI971385A0 (fi) 1997-04-04 1997-04-04 Bioxid Oy Biokompatibel komposition, metoder foer dess framstaellning samt anvaendning daerav
US7052131B2 (en) 2001-09-10 2006-05-30 J&J Vision Care, Inc. Biomedical devices containing internal wetting agents
US6822016B2 (en) * 2001-09-10 2004-11-23 Johnson & Johnson Vision Care, Inc. Biomedical devices containing internal wetting agents
US6056970A (en) * 1998-05-07 2000-05-02 Genzyme Corporation Compositions comprising hemostatic compounds and bioabsorbable polymers
US6361787B1 (en) * 1998-05-27 2002-03-26 The Clorox Company Enhanced antimicrobial composition
US20040071736A1 (en) 1998-08-25 2004-04-15 Health Protection Agency Methods and compounds for the treatment of mucus hypersecretion
AU757605B2 (en) 1999-01-28 2003-02-27 Indevus Pharmaceuticals, Inc. Hydrogel compositions useful for the sustained release of macromolecules and methods of making same
DE60024811T3 (de) 1999-05-27 2010-01-07 Acusphere, Inc., Watertown Poröse arzneistoffmatrizen und deren herstellungsverfahren
US6372251B2 (en) * 1999-06-11 2002-04-16 Abbott Laboratories Formulations comprising lipid-regulating agents
AU2001255453A1 (en) * 2000-04-18 2001-10-30 Clemson University Polylactide/dextran graft co-polymers for biomaterial and tissue engineering applications
US6969480B2 (en) 2000-05-12 2005-11-29 Matregen Corp. Method of producing structures using centrifugal forces
US20030049320A1 (en) 2000-12-18 2003-03-13 Wockhardt Limited Novel in-situ forming controlled release microcarrier delivery system
US20050004000A1 (en) 2001-04-01 2005-01-06 Yoram Shechter Oral absorbed drugs
JP4116447B2 (ja) * 2001-05-01 2008-07-09 エイ．ブイ．トップチーブ インスティテュート オブ ペトロケミカル シンセシス ヒドロゲル組成物
DE10208335A1 (de) * 2002-02-27 2003-09-04 Roehm Gmbh Arzneiform und Verfahren zu ihrer Herstellung
JP4902103B2 (ja) * 2002-04-11 2012-03-21 メディミューン・エルエルシー 凍結乾燥フォームによる生物活性材料の保存
US20040097419A1 (en) 2002-11-19 2004-05-20 Holger Petersen Organic compounds
US20040236416A1 (en) 2003-05-20 2004-11-25 Robert Falotico Increased biocompatibility of implantable medical devices
CA2437639C (en) 2003-08-11 2016-07-05 Valera Pharmaceuticals, Inc. Long term drug delivery devices with polyurethane based polymers and their manufacture
WO2005041873A2 (en) 2003-10-24 2005-05-12 Azopax Therapeutics Llc Formulation of exendin-4
US20050143303A1 (en) 2003-12-26 2005-06-30 Nastech Pharmaceutical Company Inc. Intranasal administration of glucose-regulating peptides
US20050203215A1 (en) 2004-03-11 2005-09-15 Ugazio Stephen P.J. Polymer carriers and process
TW200539903A (en) * 2004-03-12 2005-12-16 Smithkline Beecham Plc Pharmaceutical formulations
US8062652B2 (en) 2004-06-17 2011-11-22 Endo Pharmaceuticals Solutions Inc. Compositions and methods for treating precocious puberty
JP2006072100A (ja) * 2004-09-03 2006-03-16 Adtec Engineeng Co Ltd 投影露光装置
US7759312B2 (en) 2005-03-11 2010-07-20 Endo Pharmaceuticals Solutions Inc. Delivery of dry formulations of octreotide
KR101399911B1 (ko) 2005-03-11 2014-06-19 엔도 파마슈티컬즈, 솔루션스 아이엔씨. 옥트레오타이드의 방출 조절형 제형
US20070037897A1 (en) * 2005-08-12 2007-02-15 Guigui Wang Method for making contact lenses
WO2008061355A1 (en) 2006-11-24 2008-05-29 Matregen Corp. Glp-1 depot systems, and methods of manufacture and uses thereof
JP5855826B2 (ja) 2007-04-27 2016-02-09 エンド ファーマスーティカルズ ソリューションズ インコーポレイテッド．Ｅｎｄｏ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｓｏｌｕｔｉｏｎｓ Ｉｎｃ． デバイス、及びレザバーインプラントデバイスの製造方法

Also Published As

Publication number Publication date
AU2008245710B2 (en) 2013-10-17
AU2008245710A9 (en) 2013-11-28
RU2009143802A (ru) 2011-06-10
WO2008134475A3 (en) 2009-09-24
IL201734A0 (en) 2010-06-16
JP5855826B2 (ja) 2016-02-09
BRPI0810606A2 (pt) 2014-10-21
NZ580803A (en) 2012-03-30
ZA200907516B (en) 2010-07-28
US20080311170A1 (en) 2008-12-18
KR20100036225A (ko) 2010-04-07
US9120249B2 (en) 2015-09-01
CA2685397C (en) 2016-07-26
TW200906454A (en) 2009-02-16
WO2008134475A2 (en) 2008-11-06
JP2014159447A (ja) 2014-09-04
BRPI0810606B1 (pt) 2018-10-16
IL201734A (en) 2014-09-30
CN101720239A (zh) 2010-06-02
JP2016006098A (ja) 2016-01-14
TWI450734B (zh) 2014-09-01
RU2463079C2 (ru) 2012-10-10
CN101720239B (zh) 2013-12-04
KR101574354B1 (ko) 2015-12-04
EP2139533A2 (en) 2010-01-06
AU2008245710A1 (en) 2008-11-06
JP2010524652A (ja) 2010-07-22
JP5947430B2 (ja) 2016-07-06
CA2685397A1 (en) 2008-11-06

Similar Documents

Publication Publication Date Title
MX2009011641A (es) Agentes de liberacion para dispositivo de implante y metodos para utilizar los mismos.
TW200503791A (en) Absorbent polymer compositions, medical articles, and methods
IL178589A0 (en) Polymer-based sustained release device
WO2006014607A3 (en) Medical devices containing radiation resistant block copolymer
MX2007002189A (es) Sales de dicetopiperazina, sales de dicetomorfolina o sales de dicetodioxano para suministro de farmacos.
EP1651150A4 (en) INTERVERTEBRAL PROSTHESIS DEVICE AND RELEVANT DEVICES AND METHODS FOR IMPLANTING THE INTERVERTEBRAL PRESENTER DEVICE
DE602006012657D1 (de) Medizinische vorrichtungen
WO2008048821A3 (en) Mobile/fixed prosthetic knee systems
MX336209B (es) Suministro de formulaciones secas de octreótido.
EP2077283A4 (en) ETHYLENE COPOLYMER, COPOLYMER COMPOSITION, AND METHOD OF MANUFACTURE
AU2003212437A8 (en) Methods, devices, and articles for controlling the release of volatile materials
WO2006012630A3 (en) Apparatuses and methods for percutaneously implanting objects in patients
WO2009058780A3 (en) Medical implants and methods for delivering biologically active agents
WO2005120393A3 (en) Implantable device for drug delivery and improved visibility
DE602004022834D1 (de) Biologisch absorbierbare überzüge für implantierbare vorrichtungen
WO2009029049A8 (en) A bone and/or dental cement composition and uses thereof
WO2005060396A3 (en) Nanotopographic compositions and methods for cellular organization in tissue engineered structures
ATE490765T1 (de) Biologisch erodierbares pflaster
WO2001091725A3 (en) Biologically useful polyphosphates
EP1686967A4 (en) CARVEDILOL-FREE BASE, SALTS, WATER-FREE FORMS OR SOLVATES THEREOF, CORRESPONDING PHARMACEUTICAL COMPOSITIONS, CONTROLLED RELEASE FORMULAS AND TREATMENT OR DISPOSAL PROCEDURES
EP1919983A4 (en) OXIDATION-RESISTANT HOMOGENIZED POLYMER MATERIAL
MXPA05007328A (es) Composiciones que contienen agentes antiacne y el uso de las mismas.
MX2009006870A (es) Dispositivo para mitigar el olor en un articulo de ropa o calzado.
MX2009004332A (es) Formulaciones de liberacion sostenida que comprenden polimeros de peso molecular muy bajo.
WO2007008773A3 (en) Radiation resistant silicone formulations and medical devices formed of same

Legal Events

Date Code Title Description
FG Grant or registration